E-Cigarette Use Tied to Respiratory Symptoms, Wheezing

FRIDAY, Feb. 18, 2022 (HealthDay News) -- Former and current electronic cigarette use is associated with higher odds of developing wheezing-related respiratory symptoms, according to a study published online Jan. 27 in the American Journal of Respiratory and Critical Care Medicine.
Wubin Xie, Dr.P.H., from the Boston University School of Public Health, and colleagues assessed whether e-cigarette use is associated with the development of respiratory symptoms in young adults. The analysis included young adult participants (aged 18 to 24 years at baseline) in the Population Assessment of Tobacco and Health Study Waves 2 (2014-2015), 3 (2015-2016), 4 (2016-2018), and 5 (2018-2019).
The researchers found that former e-cigarette use was associated with higher odds of developing any respiratory symptom (adjusted odds ratio [aOR], 1.20), as well as wheezing in the chest (aOR, 1.41). Similar associations were seen for current e-cigarette use and higher odds for any respiratory symptom (aOR, 1.32) and wheezing in the chest (aOR, 1.51). These associations persisted even among participants who never smoked combustible cigarettes.
"The present study finds a significant prospective association of vaping with subsequent respiratory symptom development in a large, nationally representative cohort of young adults with no previous history of respiratory symptoms," a coauthor said in a statement. "This evidence highlights an urgent public health imperative for more robust regulatory standards at all levels of government to stop the youth vaping epidemic in its tracks."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Women, People of Color Wait Longer to See ED Doctor for Chest Pain
THURSDAY, May 5, 2022 (HealthDay News) -- Among young adults with chest pain...
Vaping Could Raise Teens’ Odds for Severe COVID
FRIDAY, Feb. 10, 2023 (HealthDay News) -- Healthy young people who vape or smoke...
Common COVID Drug Might Be Useful at Lower Dose
THURSDAY, March 24, 2022 (HealthDay News) -- A lower dose of a widely used...
Los refuerzos contra la COVID reducen la tasa de mortalidad en un 90 por ciento, según un estudio israelí
https://consumer.healthday.com/12-8-covid-vaccine-... Credit: HealthDay
